# Individual Patient Compassionate Use of GX-I7

> **NCT04289155** · — · NO_LONGER_AVAILABLE · sponsor: **Genexine, Inc.**

## Conditions studied

- Glioblastoma
- High Grade Glioma
- Recurrent Glioblastoma
- Melanoma
- Advanced Cancer

## Interventions

- **DRUG:** GX-I7

## Key facts

- **NCT ID:** NCT04289155
- **Lead sponsor:** Genexine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04289155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04289155, "Individual Patient Compassionate Use of GX-I7". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04289155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*